This document is the second part of a series covering in vitro diagnostic next-generation sequencing (NGS) workflows. Specifically, it focuses on human RNA testing. It provides detailed guidelines and requirements for the process, ensuring consistency and reliability in the application of NGS technology to analyze human RNA samples. The content includes considerations for sample preparation, data analysis, and quality control measures tailored to RNA-based diagnostics.
*** Please note: This description may not be accurate, please refer to the official documentation.